Similar articles for PMID: 32088128

Year	Number of Results
2008	1
2009	1
2010	2
2011	2
2012	2
2013	3
2014	5
2015	6
2016	14
2017	19
2018	17
2019	22
2020	28
2021	31
2022	8
2023	5
2024	0

1

Discovery of novel hydroxyamidine derivatives as indoleamine 2,3-dioxygenase 1 inhibitors with in vivo anti-tumor efficacy.

Liu C, Nan Y, Xia Z, Gu K, Chen C, Dong X, Ju D, Zhao W. Liu C, et al. Bioorg Med Chem Lett. 2020 Apr 15;30(8):127038. doi: 10.1016/j.bmcl.2020.127038. Epub 2020 Feb 15. Bioorg Med Chem Lett. 2020. PMID: 32088128

2

Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors.

Xia Z, Nan Y, Liu C, Lin G, Gu K, Chen C, Zhao W, Ju D, Dong X. Xia Z, et al. Anticancer Agents Med Chem. 2020;20(13):1592-1603. doi: 10.2174/1871520620666200604121225. Anticancer Agents Med Chem. 2020. PMID: 32496990

3

Discovery of phosphonamidate IDO1 inhibitors for the treatment of non-small cell lung cancer.

Du Q, Feng X, Wang Y, Xu X, Zhang Y, Qu X, Li Z, Bian J. Du Q, et al. Eur J Med Chem. 2019 Nov 15;182:111629. doi: 10.1016/j.ejmech.2019.111629. Epub 2019 Aug 18. Eur J Med Chem. 2019. PMID: 31445231

4

Discovery of novel IDO1 inhibitors targeting the protein's apo form through scaffold hopping from holo-IDO1 inhibitor.

Wu Y, Duan Q, Zou Y, Zhu Q, Xu Y. Wu Y, et al. Bioorg Med Chem Lett. 2021 Nov 15;52:128373. doi: 10.1016/j.bmcl.2021.128373. Epub 2021 Sep 21. Bioorg Med Chem Lett. 2021. PMID: 34560264

5

Design, synthesis and antitumor study of a series of N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors.

Chen S, Guo W, Liu X, Sun P, Wang Y, Ding C, Meng L, Zhang A. Chen S, et al. Eur J Med Chem. 2019 Oct 1;179:38-55. doi: 10.1016/j.ejmech.2019.06.037. Epub 2019 Jun 17. Eur J Med Chem. 2019. PMID: 31233921

6

Discovery of IDO1 and DNA dual targeting antitumor agents.

Fang K, Wu S, Dong G, Wu Y, Chen S, Liu J, Wang W, Sheng C. Fang K, et al. Org Biomol Chem. 2017 Dec 6;15(47):9992-9995. doi: 10.1039/c7ob02529g. Org Biomol Chem. 2017. PMID: 29177308

7

Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors.

Cui G, Lai F, Wang X, Chen X, Xu B. Cui G, et al. Eur J Med Chem. 2020 Feb 15;188:111985. doi: 10.1016/j.ejmech.2019.111985. Epub 2019 Dec 21. Eur J Med Chem. 2020. PMID: 31881488

8

Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO).

Pan S, Zhou Y, Wang Q, Wang Y, Tian C, Wang T, Huang L, Nan J, Li L, Yang S. Pan S, et al. Eur J Med Chem. 2020 Dec 1;207:112703. doi: 10.1016/j.ejmech.2020.112703. Epub 2020 Aug 14. Eur J Med Chem. 2020. PMID: 32871341

9

4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy.

Lin SY, Yeh TK, Song JS, Hung MS, Cheng MF, Liao FY, Li AS, Cheng SY, Lin LM, Chiu CH, Wu MH, Lin YJ, Hsiao W, Sun M, Wang YH, Huang CH, Tang YC, Chang HH, Huang ZT, Chao YS, Shih C, Pan SL, Wu SY, Kuo CC, Ueng SH. Lin SY, et al. Bioorg Chem. 2018 Apr;77:600-607. doi: 10.1016/j.bioorg.2018.02.010. Epub 2018 Feb 12. Bioorg Chem. 2018. PMID: 29494816

10

Design, synthesis, and biological evaluation of 1,2,5-oxadiazole-3-carboximidamide derivatives as novel indoleamine-2,3-dioxygenase 1 inhibitors.

Song X, Sun P, Wang J, Guo W, Wang Y, Meng LH, Liu H. Song X, et al. Eur J Med Chem. 2020 Mar 1;189:112059. doi: 10.1016/j.ejmech.2020.112059. Epub 2020 Jan 11. Eur J Med Chem. 2020. PMID: 31981851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

142 results

Results by year